Table 1.
Neurological assessment | On-phase (mean ±SD) | Off-phase (mean ±SD) | ||
---|---|---|---|---|
Age | mean ±SD | 64.81 ± 1.31 | ||
Education (years) | mean ±SD | 9.46 ± 0.98 | ||
Gender (male/female) | 19/8 | |||
years since the first symptoms appeared | median [Q1;Q3] | 10 [8;13] | ||
years since the diagnosis was made | median [Q1;Q3] | 9.5 [6.75;13] | ||
years since the dyskinesia appeared | median [Q1;Q3] | 3 [1;5] | ||
hours of Daily off | median [Q1;Q3] | 2 [0.75;4] | ||
hours of Daily on | median [Q1;Q3] | 12 [6.75;14] | ||
L-dopa (years of treatment) | mean ±SD | 8.46 ± 0.84 | ||
LEDD (mg) | mean ±SD | 982.86 ± 92.41 | ||
MDS-UPDRS total score [200] | 52.37 ± 4.33 | 76.59 ± 5.63 | ||
Part I [52] | 9.50 ± 1.56 | 10.65 ± 1.63 | ||
Part II [52] | 10.92 ± 1.20 | 15.74 ± 1.39 | ||
Part III [72] | 23.10 ± 2.75 | 40.91 ± 3.39 | ||
Part IV [24] | 10.23 ± 1.02 | 7.67 ± 0.67 | ||
Hoehn and Yahr scale [5] | 2.12 ± 0.16 | 2.44 ± 0.12 |
Maximum scores for the neurological examination are shown in square brackets. mg, milligrammes; H&Y, Hoehn and Yahr scale; SD, Standard Deviation; Q1, first quartile; Q3, third quartile; N, frequency; MDS-UPDRS, Movement Disorder Society –Unified Parkinson Disease Rating Scale.